• 

  Association of 70-Gene Signature Assay Findings With Physicians’ Treatment Guidance for Patients With Early Breast Cancer Classified as Intermediate Risk by the 21-Gene Assay

  Gallery

  Association of 70-Gene Signature Assay Findings With Physicians’ Treatment Guidance for Patients With Early Breast Cancer Classified as Intermediate Risk by the 21-Gene Assay

  Adjuvant, Evidence, MammaPrint, PROMIS

Association of 70-Gene Signature Assay Findings With Physicians’ Treatment Guidance for Patients With Early Breast Cancer Classified as Intermediate Risk by the 21-Gene Assay

PUBLICATION: JAMA Oncol. 2018; 4(1):e173470. doi:10.1001/jamaoncol.2017.3470. AUTHORS: Michaela Tsai, MD; Read More

kevin2024-03-25T08:57:37-04:00January 11th, 2018|Adjuvant, Evidence, MammaPrint, PROMIS|

Read More

• 

  Impact of 70-Gene Signature Use on Adjuvant Chemotherapy Decisions in Patients With Estrogen Receptor–Positive Early Breast Cancer: Results of a Prospective Cohort Study

  Gallery

  Impact of 70-Gene Signature Use on Adjuvant Chemotherapy Decisions in Patients With Estrogen Receptor–Positive Early Breast Cancer: Results of a Prospective Cohort Study

  Adjuvant, Evidence, MammaPrint

Impact of 70-Gene Signature Use on Adjuvant Chemotherapy Decisions in Patients With Estrogen Receptor–Positive Early Breast Cancer: Results of a Prospective Cohort Study

PUBLICATION: Journal of Clinical Oncology 35, no. 24 (August 20, Read More

kevin2024-03-25T09:02:54-04:00August 20th, 2017|Adjuvant, Evidence, MammaPrint|

Read More

• 

  Characterisation of Multifocal Breast Cancer Using the 70-gene Signature in Clinical Low-Risk Patients Enrolled in the EORTC 10041/BIG 03-04 MINDACT Trial.

  Gallery

  Characterisation of Multifocal Breast Cancer Using the 70-gene Signature in Clinical Low-Risk Patients Enrolled in the EORTC 10041/BIG 03-04 MINDACT Trial.

  Adjuvant, Evidence, MammaPrint, MINDACT

Characterisation of Multifocal Breast Cancer Using the 70-gene Signature in Clinical Low-Risk Patients Enrolled in the EORTC 10041/BIG 03-04 MINDACT Trial.

PUBLICATION: European Journal of Cancer. July 2017, Volume 79, Pages Read More

kevin2024-03-25T09:03:49-04:00July 2nd, 2017|Adjuvant, Evidence, MammaPrint, MINDACT|

Read More

• 

  A Breast Cancer Gene Signature for Indolent Disease

  Gallery

  A Breast Cancer Gene Signature for Indolent Disease

  Adjuvant, Evidence, MammaPrint, RASTER

A Breast Cancer Gene Signature for Indolent Disease

PUBLICATION: Breast Cancer Res Treat. 2017 Oct;117(3):483-95. doi: 10.1007/s10549-008-0191-2. Epub Read More

kevin2024-03-25T09:05:40-04:00July 1st, 2017|Adjuvant, Evidence, MammaPrint, RASTER|

Read More

• 

  70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer

  Gallery

  70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer

  Adjuvant, Evidence, MammaPrint, MINDACT

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer

PUBLICATION: N Engl J Med 2016; 375:717-729; DOI: 10.1056/NEJMoa1602253. AUTHORS: Read More

kevin2024-03-25T09:18:22-04:00August 25th, 2016|Adjuvant, Evidence, MammaPrint, MINDACT|

Read More

• 

  MINDACT Supplementary Appendix NEJM 2016

  Gallery

  MINDACT Supplementary Appendix NEJM 2016

  Adjuvant, Evidence, MammaPrint, MINDACT

MINDACT Supplementary Appendix NEJM 2016

SUPPLEMENTARY APPENDIX: This appendix has been provided by the authors Read More

kevin2024-03-25T09:18:44-04:00August 15th, 2016|Adjuvant, Evidence, MammaPrint, MINDACT|

Read More

• 

  Gene Expression Profiling to Predict the Risk of Locoregional Recurrence in Breast Cancer: A Pooled Analysis

  Gallery

  Gene Expression Profiling to Predict the Risk of Locoregional Recurrence in Breast Cancer: A Pooled Analysis

  Adjuvant, Evidence, MammaPrint

Gene Expression Profiling to Predict the Risk of Locoregional Recurrence in Breast Cancer: A Pooled Analysis

PUBLICATION: Breast Cancer Res Treat (2014) 148: 599. https://doi.org/10.1007/s10549-014-3188-z. AUTHORS: Read More

kevin2024-03-25T09:27:24-04:00November 24th, 2014|Adjuvant, Evidence, MammaPrint|

Read More

• 

  The Multigene Signature MammaPrint Impacts on Multidisciplinary Team Decisions in ER+, HER2− Early Breast Cancer

  Gallery

  The Multigene Signature MammaPrint Impacts on Multidisciplinary Team Decisions in ER+, HER2− Early Breast Cancer

  Adjuvant, Evidence, MammaPrint

The Multigene Signature MammaPrint Impacts on Multidisciplinary Team Decisions in ER+, HER2− Early Breast Cancer

PUBLICATION: British Journal of Cancer, volume 111, pages 837–842 (26 Read More

kevin2024-03-25T10:20:39-04:00August 26th, 2014|Adjuvant, Evidence, MammaPrint|

Read More

• 

  European Inter-Institutional Impact Study of MammaPrint

  Gallery

  European Inter-Institutional Impact Study of MammaPrint

  Adjuvant, Evidence, MammaPrint

European Inter-Institutional Impact Study of MammaPrint

PUBLICATION: The Breast August 2014, Volume 23, Issue 4, Pages Read More

kevin2024-03-25T10:07:03-04:00August 1st, 2014|Adjuvant, Evidence, MammaPrint|

Read More

• 

  Optimized Outcome Prediction in Breast Cancer by Combining the 70-Gene Signature with Clinical Risk Prediction Algorithms

  Gallery

  Optimized Outcome Prediction in Breast Cancer by Combining the 70-Gene Signature with Clinical Risk Prediction Algorithms

  Adjuvant, Evidence, MammaPrint, RASTER

Optimized Outcome Prediction in Breast Cancer by Combining the 70-Gene Signature with Clinical Risk Prediction Algorithms

PUBLICATION: Breast Cancer Res Treat. 2014 Jun;145(3):697-705. doi: 10.1007/s10549-014-2954-2. Epub Read More

kevin2024-03-25T10:21:40-04:00June 1st, 2014|Adjuvant, Evidence, MammaPrint, RASTER|

Read More